CME Sponsor:
CME Outfitters, LLC

Location: Live Webinar

Course Directors/Instructors:
Michael Racke, MD (Moderator)
Professor and Chairman in Neurology
The Helen C. Kurtz Chair in Neurology
Department of Neurology
Ohio State University Medical Center
Columbus, OH

Ralph H. B. Benedict, PhD
Professor of Neurology, Psychiatry, and Psychology
Jacobs Neurological Institute
State University of New York Buffalo School of Medicine and Biomedical Sciences
Buffalo General Hospital
Buffalo, NY

Number of Credits:
1.0 AMA PRA Category 1 Credit™

Registration Fee: Free

More Info

Detailed Description:
Cognitive impairment is common in multiple sclerosis (MS), occurs at all stages of the disease, and can be a major source of disability, social impairment, and impoverished quality of life. Even when physical disability is minimal, patients with MS are still at high risk for developing cognitive impairment. Neuropsychological assessment—including recognizing common comorbidities such as fatigue and depression—is essential when diagnosing cognitive dysfunction.

As cognition is increasingly recognized as a major feature of MS, physicians need education that will increase confidence in their ability to provide patients with accurate assessment, rehabilitation, and management. An integration of both pharmacological and nonpharmacological treatments may play an increasing role in the optimal management and targeting of cognitive deficits.

This neuroscienceCME Webcast will provide clinicians with an opportunity to evaluate the latest evidence surrounding assessment and potential management of cognitive dysfunction in patients with MS with a goal of improving patients’ health-related quality of life.



Learning Objectives:
At the end of this CE activity, participants should be able to:
  • Define the quality of life (QOL) effects of cognitive dysfunction in multiple sclerosis Apply techniques for neuropsychological assessment of cognitive impairment to facilitate early and accurate diagnosis of cognitive dysfunction in multiple sclerosis (MS).
  • Compare and contrast pharmacological and nonpharmacological therapies for the treatment of cognitive dysfunction in MS, then translate that knowledge into improved, individualized therapy for patients.

Intended Audience:
The activity is designed for physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other healthcare professionals with an interest in multiple sclerosis.